Copyright
©2013 Baishideng Publishing Group Co.
World J Hepatol. May 27, 2013; 5(5): 264-274
Published online May 27, 2013. doi: 10.4254/wjh.v5.i5.264
Published online May 27, 2013. doi: 10.4254/wjh.v5.i5.264
Ref. | Biopsies (n) | Prevalence of cirrhosis (F4) | Etiologies | Proposed cutoff values (kPa) | Sensitivity | Specificity | NPV | PPV | Positive LR | Negative LR | AUROC |
Castéra et al[4], 2005 | 183 | 25% | HCV | 12.5 | 87% | 91% | 95% | 77% | 9.7 | 0.1 | 0.95 |
Fraquelli et al[23], 2007 | 200 | 12% | All | 11.9 | 91% | 89% | 98% | 53% | 8.3 | 0.1 | 0.9 |
Arena et al[24], 2008 | 150 | 19.3% | HCV | 14.8 | 94% | 92% | 98% | 73% | 11.3 | 0.07 | 0.99 |
Ziol et al[25], 2005 | 251 | 19% | HCV | 14.6 | 86% | 96% | 97% | 78% | 23.1 | 0.1 | 0.97 |
Chan et al[26], 2009 | 161 | 25% | HBV | 13.4 | 60% | 93% | 88% | 75% | 85 | 0.43 | 0.93 |
Marcellin et al[27], 2009 | 173 | 8% | HBV | 11 | 93% | 87% | 99% | 38% | 7 | 0.08 | 0.93 |
Wong et al[28], 20101 | 238 | 23.5% | HBV | 9.0 (normal ALT) 12.0 (elevated ALT) | 54% | 99% | 67% | 98% | 3.3 | 0.7 | 0.88 |
de Lédinghen et al[29], 2006 | 72 | 23.6% | HCV-HIV | 11.8 | 100% | 92.7% | 82% | 100% | 13.7 | 0 | 0.97 |
Nobili et al[30], 20081 | 52 | 5.8% | NAFLD | 10.2 | 100% | 100% | 100% | 100% | ∞ | 0 | 1 |
Wong et al[31], 2010 | 246 | 10.1% | NAFLD | 10.3 | 92% | 88% | 99% | 46% | 7.5 | 0.09 | 0.95 |
Nahon et al[32], 2008 | 174 | 53.7% | ALD | 22.7 | 84% | 83% | 82% | 85% | 5.24 | 0.19 | 0.87 |
Corpechot et al[33], 2006 | 95 (66 PBC, 29 PSC) | 16% | PBC/PSC | 17.3 | 93% | 95% | 99% | 78% | 18.6 | 0.1 | 0.96 |
Carrión et al[34], 2006 | 124 | 11% | HCV-LT | 12.5 | 100% | 87% | 100% | 50% | 7.7 | 0 | 0.98 |
Witters et al[36], 2009 | 66 | NA | Cystic fibrosis | 6.5 | 100% | 81% | NA | NA | NA | NA | 0.92 |
Coco et al[75], 2007 | 228 | 20.2% | HCV/HBV | 14 | 78% | 98% | 82% | 98% | 39 | 0.2 | 0.96 |
Ganne-Carrié et al[106], 2006 | 775 | 15.5% | All | 14.6 | 79% | 95% | 96% | 74% | 15.8 | 0.1 | 0.95 |
Foucher et al[107], 2006 | 354 | 13.3% | All | 17.6 | 77% | 97% | 92% | 91% | 25.7 | 0.2 | 0.96 |
Gómez-Domínguez et al[108], 2006 | 94 | 17% | All | 16 | 89% | 96% | 98% | 80% | 22.3 | 0.1 | 0.94 |
Vergara et al[109], 2007 | 169 | 38.5% | HCV-HIV | 14.6 | 93% | 88% | 94% | 86% | 7.8 | 0.1 | 0.95 |
Rigamonti et al[110], 2008 | 95 | 17% | HCV-LT | 12 | 93% | 93% | 99% | 74% | 14 | 0.1 | 0.9 |
Yoneda et al[111], 2007 | 67 | 7.5% | NAFLD | 17 | 100% | 98% | 95% | 64% | 50 | 0 | 0.99 |
- Citation: Wong GLH. Transient elastography: Kill two birds with one stone? World J Hepatol 2013; 5(5): 264-274
- URL: https://www.wjgnet.com/1948-5182/full/v5/i5/264.htm
- DOI: https://dx.doi.org/10.4254/wjh.v5.i5.264